Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Karyopharm Therapeutics Received FDA Approval for Labeling for XPOVIO

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208088
byCharles Gross
March 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208088

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0